What best means in this list
Best means the highest stored NexusTrade report ratings within this selection. Ratings use the product's 1-to-5 scale. The list sorts by rating from high to low, with ticker order breaking equal-rating ties. A rating summarizes a report; it does not predict a stock's return.
Companies belong to the Pharmaceuticals classification, based on company products and revenue. Classifications can overlap, so a company may appear in several industry lists.
Ratings and dated fundamentals
| 1 | Exelixis Inc | EXEL | 4.5 | 2025-10-27 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $59.02 | $14,624,075,461.84 | 16.99 | 7.93 |
| 2 | Amphastar Pharmaceuticals, Inc. | AMPH | 4 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $25.81 | $1,097,904,334.64 | 13.98 | 1.43 |
| 3 | CorMedix Inc. | CRMD | 4 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.32 | $570,552,451.68 | 3.05 | 1.24 |
| 4 | Halozyme Therapeutics, Inc. | HALO | 4 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $109.84 | $12,466,620,320 | 30.14 | 86.85 |
| 5 | Johnson & Johnson | JNJ | 4 | 2025-10-22 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $256.48 | $618,090,792,158.56 | 29.38 | 7.27 |
| 6 | Krystal Biotech, Inc. Common Stock | KRYS | 4 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $327.3 | $9,687,699,022.8 | 40.12 | 7.13 |
| 7 | Eli Lilly & Co. | LLY | 4 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1,169.6 | $1,101,011,223,224 | 41.22 | 32.5 |
| 8 | Neurocrine Biosciences Inc | NBIX | 4 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $141.25 | $14,357,946,816.25 | 20.35 | 3.89 |
| 9 | Regeneron Pharmaceuticals Inc | REGN | 4 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $739.57 | $76,142,420,475.16 | 17.59 | 2.4 |
| 10 | United Therapeutics Corp | UTHR | 4 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $532.78 | $22,851,302,883.76 | 17.43 | 3.57 |
| 11 | Abbott Laboratories | ABT | 3.5 | 2025-10-15 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $98.49 | $170,425,450,823.04 | 31.41 | Not reported |
| 12 | IDEAYA Biosciences, Inc. Common Stock | IDYA | 3.5 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $36.06 | $3,479,410,793.04 | Not reported | 2.9 |
| 13 | Ligand Pharmaceuticals Inc. | LGND | 3.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $295 | $5,881,004,655 | 29.82 | 6.08 |
| 14 | Lantheus Holdings, Inc | LNTH | 3.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $100.12 | $6,535,069,584.28 | 23.74 | 4.98 |
| 15 | Merck & Co., Inc. | MRK | 3.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $142.38 | $351,275,897,818.44 | 110.71 | Not reported |
| 16 | Novo-Nordisk A/S | NVO | 3.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $38.18 | $169,671,920,000 | 10.94 | 5.57 |
| 17 | Rigel Pharmaceuticals Inc. (New) | RIGL | 3.5 | 2025-08-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $48.72 | $910,082,974.08 | 2.83 | 2.14 |
| 18 | Thermo Fisher Scientific, Inc. | TMO | 3.5 | 2025-10-31 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $651.98 | $241,067,835,526.28 | 34.62 | Not reported |
| 19 | Travere Therapeutics, Inc. Common Stock | TVTX | 3.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $52.04 | $4,905,346,707.28 | Not reported | 200.04 |
| 20 | Acadia Pharmaceuticals Inc. | ACAD | 3 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $19.58 | $3,373,742,042.44 | 8.87 | 2.58 |
| 21 | ADMA Biologics, Inc. | ADMA | 3 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $10.33 | $2,313,761,744.4 | 13.69 | 5.67 |
| 22 | Alkermes Inc. plc | ALKS | 3 | 2025-10-23 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $40.11 | $6,728,984,839.92 | 101.76 | 3.72 |
| 23 | Alnylam Pharmaceuticals, Inc. | ALNY | 3 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $224.53 | $30,044,161,264.54 | 37.18 | 22.19 |
| 24 | Amgen Inc | AMGN | 3 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $407.44 | $220,275,104,117.2 | 25.19 | Not reported |
| 25 | Arrowhead Research Corporation | ARWR | 3 | 2025-12-01 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $60.74 | $8,579,796,325.58 | Not reported | 18.41 |
| 26 | Axsome Therapeutics, Inc | AXSM | 3 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $170.08 | $8,908,929,525.44 | Not reported | 106.94 |
| 27 | BioMarin Pharmaceuticals Inc | BMRN | 3 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $54.89 | $10,625,263,631.51 | 145.61 | 1.68 |
| 28 | Corcept Therapeutics Inc. | CORT | 3 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $118.54 | $12,813,983,980.38 | 232.21 | 18.16 |
| 29 | Delcath Systems Inc | DCTH | 3 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.04 | $521,869,876.8 | 980.96 | 4.31 |
| 30 | GE HealthCare Technologies Inc. Common Stock | GEHC | 3 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $64.22 | $29,213,150,496.92 | 14.72 | 2.6 |
| 31 | Innoviva, Inc. Common Stock | INVA | 3 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $20.87 | $1,507,763,271.95 | Not reported | Not reported |
| 32 | Mirum Pharmaceuticals, Inc. Common Stock | MIRM | 3 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $81.35 | $5,282,234,714.05 | Not reported | Not reported |
| 33 | Mannkind Corporation | MNKD | 3 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.42 | $1,099,668,978.54 | Not reported | Not reported |
| 34 | Pfizer Inc. | PFE | 3 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $27.82 | $158,564,919,245.98 | 36.59 | 1.85 |
| 35 | Supernus Pharmaceuticals, Inc. | SUPN | 3 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $42.14 | $2,449,472,327.82 | Not reported | 2.38 |
| 36 | Tarsus Pharmaceuticals, Inc. Common Stock | TARS | 3 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $72.22 | $3,169,229,971.12 | Not reported | 9.14 |
| 37 | Tango Therapeutics, Inc. | TNGX | 3 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $22.57 | $3,805,535,983.19 | Not reported | 3.71 |
| 38 | Vericel Corporation | VCEL | 3 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $40.05 | $2,050,824,890.7 | 84.67 | 5.54 |
| 39 | Viking Therapeutics, Inc | VKTX | 3 | 2025-10-23 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $27.73 | $3,234,785,943.01 | Not reported | 7.92 |
| 40 | Vertex Pharmaceuticals Inc | VRTX | 3 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $503.25 | $127,554,210,003 | 28.96 | 6.3 |
| 41 | Adaptive Biotechnologies Corporation Common Stock | ADPT | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $26.09 | $4,163,855,517.78 | Not reported | 27.64 |
| 42 | Amneal Pharmaceuticals, Inc. Class A Common Stock | AMRX | 2.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $19.65 | $6,275,304,508.35 | 39.88 | 53.64 |
| 43 | Ardelyx, Inc. | ARDX | 2.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.27 | $814,843,360.44 | Not reported | 5.47 |
| 44 | Arcutis Biotherapeutics, Inc. Common Stock | ARQT | 2.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $24.49 | $3,078,196,124.89 | 107.93 | 13.96 |
| 45 | Biogen Inc. Common Stock | BIIB | 2.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $218.43 | $32,248,375,466.31 | 38.64 | 1.71 |
| 46 | Collegium Pharmaceutical, Inc. Common Stock | COLL | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $22.11 | $719,804,603.43 | 15.02 | 2.31 |
| 47 | CytomX Therapeutics, Inc. | CTMX | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.47 | $538,211,231.48 | Not reported | 1.78 |
| 48 | Eton Pharmaceutcials, Inc. Common Stock | ETON | 2.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $54.75 | $1,564,926,641.25 | 123.34 | 33.59 |
| 49 | Gilead Sciences Inc | GILD | 2.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $147.1 | $182,397,403,300.5 | Not reported | Not reported |
| 50 | Harrow, Inc. Common Stock | HROW | 2.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $30.52 | $1,144,129,182 | Not reported | 77.07 |
| 51 | Immunovant, Inc. Common Stock | IMVT | 2.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $30.26 | $6,250,284,157.32 | Not reported | 8.5 |
| 52 | Incyte Genomics Inc | INCY | 2.5 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $112.75 | $22,660,234,209.25 | 14.05 | 3.57 |
| 53 | Iovance Biotherapeutics, Inc. Common Stock | IOVA | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $13.31 | $6,029,049,759.92 | Not reported | 8.19 |
| 54 | IQVIA Holdings Inc. | IQV | 2.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $258.88 | $42,611,648,000 | 30.99 | 6.76 |
| 55 | Keros Therapeutics, Inc. Common Stock | KROS | 2.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $11.64 | $230,788,468.32 | Not reported | 0.88 |
| 56 | Kymera Therapeutics, Inc. Common Stock | KYMR | 2.5 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $109.3 | $9,088,362,547.4 | Not reported | 6.02 |
| 57 | Nurix Therapeutics, Inc. Common stock | NRIX | 2.5 | 2025-10-09 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $22.21 | $2,304,991,179.43 | Not reported | 5.72 |
| 58 | PUMA BIOTECHNOLOGY INC | PBYI | 2.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $9.97 | $514,652,058.02 | 19.26 | 3.71 |
| 59 | Pacira BioSciences, Inc. Common Stock | PCRX | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $36.39 | $1,450,574,031.54 | 99.1 | 2.16 |
| 60 | Vaxcyte, Inc. Common Stock | PCVX | 2.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $65.02 | $9,674,575,149.17 | Not reported | 3.51 |
| 61 | Pliant Therapeutics, Inc. Common Stock | PLRX | 2.5 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1 | $61,921,897 | Not reported | 0.42 |
| 62 | Prothena Corporation plc Ordinary Shares | PRTA | 2.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $8.61 | $442,011,346.14 | Not reported | 1.54 |
| 63 | Protagonist Therapeutics, Inc | PTGX | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $139.91 | $9,053,336,154.35 | 109.2 | 10.76 |
| 64 | Arcus Biosciences, Inc. | RCUS | 2.5 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $23.83 | $3,034,354,350.08 | Not reported | Not reported |
| 65 | SIGA Technologies Inc. | SIGA | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.28 | $235,667,068.48 | Not reported | 1.43 |
| 66 | Sanofi American Depositary Shares (Each representing one-half of one ordinary share) | SNY | 2.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $40.23 | $98,115,104,144.16 | 11.06 | Not reported |
| 67 | Sarepta Therapeutics,, Inc. Common Stock | SRPT | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $18.21 | $1,923,468,052.41 | Not reported | 1.26 |
| 68 | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | TAK | 2.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $18.52 | $60,614,836,586.51 | Not reported | 1.29 |
| 69 | TG Therapeutics, Inc. | TGTX | 2.5 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $53.34 | $8,164,703,287.02 | 18.49 | 13.52 |
| 70 | Zymeworks Inc. | ZYME | 2.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $25.26 | $1,792,430,427.66 | Not reported | 22.3 |
| 71 | AbCellera Biologics Inc. Common Shares | ABCL | 2 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $12.02 | $3,685,469,821.32 | Not reported | 4.11 |
| 72 | Acumen Pharmaceuticals, Inc. Common Stock | ABOS | 2 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.1 | $151,866,298.5 | Not reported | 2.65 |
| 73 | Arbutus Biopharma Corporation Common Stock | ABUS | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.18 | $827,003,950.3 | 5.4 | 3.2 |
| 74 | Aclaris Therapeutics, Inc. | ACRS | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.79 | $557,883,804.47 | Not reported | 4.48 |
| 75 | Agios Pharmaceuticals, Inc. | AGIO | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $31.92 | $1,905,684,073.44 | Not reported | 1.86 |
| 76 | Alumis Inc. Common Stock | ALMS | 2 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $6.97 | $902,163,615.83 | Not reported | 2 |
| 77 | ANI Pharmaceuticals, Inc. | ANIP | 2 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $71.98 | $1,653,405,936.96 | 15.27 | 2.77 |
| 78 | Annexon, Inc. Common Stock | ANNX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4 | $597,451,200 | Not reported | 3.21 |
| 79 | Arcturus Therapeutics Holdings Inc. Common Stock | ARCT | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $12.87 | $365,804,898.03 | Not reported | 2.13 |
| 80 | Arvinas, Inc | ARVN | 2 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $7.51 | $491,050,294.41 | 52.8 | 0.87 |
| 81 | Atara Biotherapeutics, Inc | ATRA | 2 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $9.23 | $92,648,063.3 | Not reported | Not reported |
| 82 | Anavex Life Sciences | AVXL | 2 | 2025-12-22 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.54 | $142,753,136.68 | Not reported | 1.27 |
| 83 | BridgeBio Pharma, Inc. Common Stock | BBIO | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $65.04 | $12,714,505,308.96 | Not reported | Not reported |
| 84 | Black Diamond Therapeutics, Inc. Common Stock | BDTX | 2 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.81 | $103,991,282.07 | Not reported | 1.08 |
| 85 | BioAge Labs, Inc. Common Stock | BIOA | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.21 | $285,019,804.89 | Not reported | 0.76 |
| 86 | Bausch + Lomb Corporation | BLCO | 2 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $17.15 | $6,125,383,968.9 | Not reported | 0.95 |
| 87 | Bristol-Myers Squibb Co. | BMY | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $59.58 | $121,704,939,204.48 | 13.11 | 5.45 |
| 88 | Cullinan Therapeutics, Inc. Common Stock | CGEM | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.46 | $994,923,569.24 | Not reported | 3.09 |
| 89 | Celldex Therapeutics, Inc | CLDX | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $29.3 | $2,300,915,287.6 | Not reported | 3.22 |
| 90 | Compass Therapeutics, Inc. Common Stock | CMPX | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.98 | $177,098,455.61 | Not reported | 1.07 |
| 91 | Cardiff Oncology, Inc. Common Stock | CRDF | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.06 | $82,462,963.94 | Not reported | 3.11 |
| 92 | Corvus Pharmaceuticals, Inc. | CRVS | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.21 | $858,874,838.24 | Not reported | 3.81 |
| 93 | Cytokinetics Inc. | CYTK | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $62.01 | $8,620,842,150.18 | Not reported | Not reported |
| 94 | Design Therapeutics, Inc. Common Stock | DSGN | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11.49 | $719,063,169.99 | Not reported | 3.56 |
| 95 | Dyne Therapeutics, Inc. Common Stock | DYN | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $16.37 | $3,057,039,075.47 | Not reported | 4.35 |
| 96 | Emergent Biosolutions, Inc. | EBS | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.81 | $349,171,418.16 | Not reported | 1.02 |
| 97 | Enliven Therapeutics, Inc. Common Stock | ELVN | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $40.63 | $2,976,991,019.43 | Not reported | 3.33 |
| 98 | Edgewise Therapeutics, Inc. Common Stock | EWTX | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $39.23 | $4,260,539,980.67 | Not reported | 9.51 |
| 99 | Fulgent Genetics, Inc. Common Stock | FLGT | 2 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $20.82 | $572,868,400.26 | Not reported | 0.58 |
| 100 | Fulcrum Therapeutics, Inc. Common Stock | FULC | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.75 | $286,114,713.75 | Not reported | 0.92 |
| 101 | Geron Corp | GERN | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.22 | $783,817,558.98 | Not reported | 3.59 |
| 102 | Glaukos Corporation | GKOS | 2 | 2025-10-31 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $161.29 | $9,513,519,198.73 | Not reported | 13.94 |
| 103 | Genelux Corporation Common Stock | GNLX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.5 | $113,113,337.5 | Not reported | 7.02 |
| 104 | Structure Therapeutics Inc. American Depositary Shares | GPCR | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $25.67 | $1,830,524,037.75 | Not reported | 1.35 |
| 105 | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | GSK | 2 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $46.54 | $100,420,405,755.02 | 12.11 | 4.68 |
| 106 | HUTCHMED (China) Limited American Depositary Shares | HCM | 2 | 2025-11-28 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $13.67 | $2,384,943,713.08 | 5.22 | 1.91 |
| 107 | Disc Medicine, Inc. Common Stock | IRON | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $60.77 | $2,333,133,129.88 | Not reported | 3.62 |
| 108 | Janux Therapeutics, Inc. Common Stock | JANX | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $18.5 | $1,131,030,300.5 | Not reported | 1.22 |
| 109 | Kura Oncology, Inc. | KURA | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.52 | $935,865,711.88 | Not reported | 19.32 |
| 110 | Kyverna Therapeutics, Inc. Common Stock | KYTX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.18 | $382,192,483.92 | Not reported | 2.31 |
| 111 | Liquidia Corporation Common Stock | LQDA | 2 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $28.02 | $2,508,039,125.82 | 18.09 | 12.85 |
| 112 | Madrigal Pharmaceuticals, Inc. Common Stock | MDGL | 2 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $476.91 | $11,018,588,730.66 | Not reported | 21.04 |
| 113 | MacroGenics, Inc. | MGNX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.55 | $226,135,663.85 | Not reported | 5.27 |
| 114 | Metagenomi Therapeutics, Inc. Common Stock | MGX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.99 | $37,520,220.69 | Not reported | 0.33 |
| 115 | Mineralys Therapeutics, Inc. Common Stock | MLYS | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $22.38 | $1,978,546,086.3 | Not reported | 3.59 |
| 116 | Moderna, Inc. Common Stock | MRNA | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $197 | $78,649,470,133 | Not reported | 11.63 |
| 117 | Nkarta, Inc. Common Stock | NKTX | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.22 | $159,007,036.02 | Not reported | 0.64 |
| 118 | Neumora Therapeutics, Inc. Common Stock | NMRA | 2 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.48 | $90,152,458.58 | Not reported | 2.03 |
| 119 | Nuvectis Pharma, Inc. Common Stock | NVCT | 2 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $20.13 | $655,866,259.29 | Not reported | 72.22 |
| 120 | Ocugen, Inc. Common Stock | OCGN | 2 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.98 | $331,446,505.94 | Not reported | Not reported |
| 121 | Organon & Co. | OGN | 2 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $13.75 | $3,610,879,703.75 | 17.28 | 3.59 |
| 122 | Olema Pharmaceuticals, Inc. Common Stock | OLMA | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.82 | $684,231,286.74 | Not reported | 1.59 |
| 123 | Phathom Pharmaceuticals, Inc. Common Stock | PHAT | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.13 | $576,823,659.42 | Not reported | Not reported |
| 124 | Protalix BioTherapeutics, Inc. Common Stock | PLX | 2 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.7 | $217,543,433.4 | 11.48 | 3.05 |
| 125 | Rocket Pharmaceuticals, Inc. Common Stock | RCKT | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.63 | $288,707,190.11 | Not reported | 0.78 |
| 126 | Replimune Group, Inc. | REPL | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $13.04 | $1,228,624,027.36 | Not reported | 11.63 |
| 127 | Relay Therapeutics, Inc. Common Stock | RLAY | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $17.41 | $3,815,255,795.71 | Not reported | 4.29 |
| 128 | Atrium Therapeutics, Inc. Common Stock | RNA | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $8.26 | $141,292,611.18 | Not reported | 0.66 |
| 129 | Rhythm Pharmaceuticals, Inc. Common Stock | RYTM | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $89.64 | $6,171,900,630.48 | Not reported | 28.4 |
| 130 | Scholar Rock Holding Corporation Common Stock | SRRK | 2 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $42.2 | $5,139,338,900.4 | Not reported | 20.25 |
| 131 | Stoke Therapeutics, Inc. Common Stock | STOK | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $23.95 | $1,545,403,495.9 | Not reported | 4.47 |
| 132 | Savara Inc. | SVRA | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.83 | $992,371,872.45 | Not reported | 6.91 |
| 133 | TScan Therapeutics, Inc. Common Stock | TCRX | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.23 | $15,467,225.99 | Not reported | 0.22 |
| 134 | Teva Pharmaceutical Industries Limited | TEVA | 2 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $39.25 | $45,737,871,297 | 64.69 | 5.9 |
| 135 | United-Guardian, Inc. | UG | 2 | 2025-08-08 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $7.11 | $32,645,393.09 | 13.24 | 2.81 |
| 136 | UroGen Pharma Ltd. Ordinary Shares | URGN | 2 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $36.98 | $1,807,603,256.72 | Not reported | Not reported |
| 137 | Xeris Biopharma Holdings, Inc. Common Stock | XERS | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $10.19 | $1,857,843,918.14 | Not reported | Not reported |
| 138 | Xencor, Inc. | XNCR | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $24.5 | $1,821,658,226.5 | Not reported | 3.62 |
| 139 | Zentalis Pharmaceuticals, Inc. Common Stock | ZNTL | 2 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.51 | $179,896,504.14 | Not reported | 1.25 |
| 140 | ABBVIE INC. | ABBV | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $272.42 | $481,398,090,779.7 | 76.29 | Not reported |
| 141 | Abeona Therapeutics Inc. Common Stock | ABEO | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.96 | $283,632,724.32 | Not reported | 2.21 |
| 142 | Acrivon Therapeutics, Inc. Common Stock | ACRV | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.87 | $80,135,786.94 | Not reported | 0.92 |
| 143 | Actuate Therapeutics, Inc. Common stock | ACTU | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.68 | $16,305,643.16 | Not reported | 16.48 |
| 144 | Adial Pharmaceuticals, Inc | ADIL | 1.5 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.97 | $10,424,783.3 | Not reported | 66.83 |
| 145 | Akebia Therapeutics, Inc. | AKBA | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.81 | $225,786,168.43 | Not reported | 9.02 |
| 146 | Aldeyra Therapeutics, Inc. | ALDX | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.95 | $57,171,349.18 | Not reported | 1.51 |
| 147 | Allogene Therapeutics, Inc. Common Stock | ALLO | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.4 | $483,687,233.4 | Not reported | 1.11 |
| 148 | Altimmune, Inc. Common Stock | ALT | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.6 | $505,746,022.6 | Not reported | 1.07 |
| 149 | Amylyx Pharmaceuticals, Inc. Common Stock | AMLX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $27.2 | $3,030,706,905.6 | Not reported | 12.67 |
| 150 | AN2 Therapeutics, Inc. Common Stock | ANTX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.68 | $176,605,589.16 | Not reported | 2.33 |
| 151 | Aprea Therapeutics, Inc. Common stock | APRE | 1.5 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.56 | $7,028,372.12 | Not reported | Not reported |
| 152 | Aquestive Therapeutics, Inc. Common Stock | AQST | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.76 | $597,435,444.48 | Not reported | Not reported |
| 153 | Assembly Biosciences, Inc | ASMB | 1.5 | 2025-08-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $22.82 | $464,628,800.72 | Not reported | 1.52 |
| 154 | Actinium Pharmaceuticals, Inc | ATNM | 1.5 | 2025-11-24 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.08 | $33,956,750.88 | 3 | 1.12 |
| 155 | ArriVent BioPharma, Inc. Common Stock | AVBP | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $16.71 | $823,932,151.59 | Not reported | 2.25 |
| 156 | AYTU BioPharma, Inc. Common Stock | AYTU | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.05 | $22,276,751.4 | Not reported | 0.63 |
| 157 | Baxter International Inc. | BAX | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $23.9 | $12,356,204,376.1 | Not reported | 2 |
| 158 | Bicara Therapeutics Inc. Common Stock | BCAX | 1.5 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $17.26 | $1,142,144,840.84 | Not reported | 2.44 |
| 159 | BioCryst Pharmaceuticals Inc | BCRX | 1.5 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $8.29 | $2,118,386,020.45 | Not reported | Not reported |
| 160 | Bullfrog AI Holdings, Inc. Common Stock | BFRG | 1.5 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.69 | $12,838,239.15 | Not reported | 1.84 |
| 161 | BGM Group Ltd. Class A Ordinary Shares | BGM | 1.5 | 2025-07-24 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $9.96 | $133,006,945.56 | Not reported | 0.34 |
| 162 | Biohaven Ltd. | BHVN | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11.93 | $1,801,952,307.33 | Not reported | 147.44 |
| 163 | Biomea Fusion, Inc. Common Stock | BMEA | 1.5 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.37 | $99,302,877.24 | Not reported | 8.18 |
| 164 | Boundless Bio, Inc. Common Stock | BOLD | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.58 | $58,689,801.3 | Not reported | 0.89 |
| 165 | BeyondSpring Inc. Ordinary Shares | BYSI | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.61 | $25,041,970.38 | Not reported | Not reported |
| 166 | Candel Therapeutics, Inc. Common Stock | CADL | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $9.66 | $739,169,337.9 | Not reported | 5.86 |
| 167 | CalciMedica, Inc. Common Stock | CALC | 1.5 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.3 | $8,876,779.6 | Not reported | 1.61 |
| 168 | Capricor Therapeutics Inc | CAPR | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $8.01 | $465,693,301.89 | Not reported | 1.89 |
| 169 | C4 Therapeutics, Inc. | CCCC | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.85 | $350,621,637.6 | Not reported | 1.42 |
| 170 | Compugen Ltd | CGEN | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.12 | $200,823,203.12 | 5.68 | 1.95 |
| 171 | Cognition Therapeutics, Inc. Common Stock | CGTX | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.9 | $85,127,921.42 | Not reported | 2.58 |
| 172 | Coherus Oncology, Inc. Common Stock | CHRS | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.07 | $165,316,033.62 | Not reported | 2.72 |
| 173 | Calidi Biotherapeutics, Inc. | CLDI | 1.5 | 2025-08-08 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.04 | $2,687,551.36 | Not reported | 0.86 |
| 174 | Connect Biopharma Holdings Limited Ordinary Shares | CNTB | 1.5 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.88 | $55,461,473.94 | Not reported | 2.06 |
| 175 | Cosmos Holdings Inc. Common Stock | COSM | 1.5 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-09 | $0.34 | $33,802,884.35 | Not reported | 1.64 |
| 176 | Coya Therapeutics, Inc. Common Stock | COYA | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.99 | $117,054,666.51 | Not reported | 2.7 |
| 177 | Cumberland Pharmaceuticals Inc | CPIX | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $6.98 | $104,582,086.86 | Not reported | 6.11 |
| 178 | Corbus Pharmaceuticals Holdings, Inc. | CRBP | 1.5 | 2025-08-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $5.27 | $101,928,614.11 | Not reported | 1 |
| 179 | Curis Inc | CRIS | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.71 | $1,482,700.62 | Not reported | 0.32 |
| 180 | CRISPR Therapeutics AG | CRSP | 1.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $50.44 | $4,877,177,417.32 | Not reported | 2.79 |
| 181 | Contineum Therapeutics, Inc. Class A Common Stock | CTNM | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $13.18 | $495,846,519.76 | Not reported | 2.07 |
| 182 | Citius Oncology, Inc. Common Stock | CTOR | 1.5 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.84 | $77,639,305.34 | Not reported | 1.92 |
| 183 | Cue Biopharma, Inc. | CUE | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $22.33 | $162,214,364.62 | Not reported | 70.22 |
| 184 | Curanex Pharmaceuticals Inc Common Stock | CURX | 1.5 | 2025-09-09 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.76 | $7,464,827.16 | Not reported | 1.56 |
| 185 | Cadrenal Therapeutics, Inc. Common Stock | CVKD | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.93 | $3,316,433.52 | Not reported | 0.81 |
| 186 | Journey Medical Corporation Common Stock | DERM | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $5.95 | $167,935,150.25 | Not reported | 5.23 |
| 187 | Denali Therapeutics Inc. Common Stock | DNLI | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $18.67 | $2,984,351,014.01 | Not reported | 3.57 |
| 188 | Precision BioSciences, Inc. Common Stock | DTIL | 1.5 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.43 | $177,477,992.22 | Not reported | 3.92 |
| 189 | Editas Medicine, Inc. Common Stock | EDIT | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.84 | $436,167,299.4 | Not reported | 4.14 |
| 190 | Enanta Pharmaceuticals, Inc | ENTA | 1.5 | 2025-12-01 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $12.1 | $352,417,364.2 | Not reported | 3.49 |
| 191 | Evolus, Inc. Common Stock | EOLS | 1.5 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.8 | $515,193,432 | Not reported | Not reported |
| 192 | EyePoint, Inc. Common Stock | EYPT | 1.5 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.46 | $298,293,997.48 | Not reported | 1.79 |
| 193 | Fortress Biotech, Inc. | FBIO | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.09 | $69,620,015.08 | 0.62 | 0.34 |
| 194 | Fennec Pharmaceuticals Inc. Common Stock | FENC | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.63 | $372,763,900.17 | Not reported | 8.78 |
| 195 | Foghorn Therapeutics Inc. Common Stock | FHTX | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.99 | $118,176,776.85 | Not reported | Not reported |
| 196 | Greenwich LifeSciences, Inc. | GLSI | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.14 | $222,228,069.12 | Not reported | 71.3 |
| 197 | Monte Rosa Therapeutics, Inc. Common Stock | GLUE | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.32 | $880,434,298.32 | Not reported | 1.81 |
| 198 | Grace Therapeutics, Inc. Common Stock | GRCE | 1.5 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.04 | $42,913,297.2 | Not reported | 0.89 |
| 199 | Gyre Therapeutics, Inc. Common Stock | GYRE | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.76 | $753,806,579.24 | Not reported | 4.57 |
| 200 | Werewolf Therapeutics, Inc. Common Stock | HOWL | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.91 | $44,225,150.06 | Not reported | 2.71 |
| 201 | MindWalk Holdings Corp. Common Stock | HYFT | 1.5 | 2025-12-15 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.43 | $67,369,685.24 | Not reported | 7.79 |
| 202 | ImmunityBio, Inc. Common Stock | IBRX | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $9.91 | $10,502,977,465.43 | Not reported | Not reported |
| 203 | Immix Biopharma, Inc. Common Stock | IMMX | 1.5 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $9.29 | $664,600,227.06 | Not reported | 2.9 |
| 204 | Immunic, Inc. Common Stock | IMUX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.56 | $103,152,170.52 | Not reported | 0.81 |
| 205 | IN8bio, Inc. Common Stock | INAB | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.38 | $13,604,568.54 | Not reported | 0.74 |
| 206 | Inhibrx Biosciences, Inc. Common Stock | INBX | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $92.76 | $1,365,210,141.6 | Not reported | Not reported |
| 207 | Indivior Pharmaceuticals, Inc. Common Stock | INDV | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $35.45 | $4,183,583,857.05 | 11.75 | Not reported |
| 208 | Insmed, Inc. | INSM | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $100.48 | $21,942,973,421.44 | Not reported | 28.97 |
| 209 | Ionis Pharmaceuticals, Inc. Common Stock | IONS | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $43.3 | $7,195,781,142.6 | Not reported | 16.36 |
| 210 | Invivyd, Inc. Common Stock | IVVD | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.7 | $206,449,025.7 | Not reported | 1.14 |
| 211 | KALA BIO, Inc. Common Stock | KALA | 1.5 | 2025-08-08 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.3 | $5,736,180.53 | Not reported | 0.63 |
| 212 | Karyopharm Therapeutics Inc. | KPTI | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.6 | $13,608,876 | Not reported | Not reported |
| 213 | LENZ Therapeutics, Inc. Common Stock | LENZ | 1.5 | 2025-07-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.53 | $110,913,810.79 | Not reported | 0.51 |
| 214 | Lexaria Bioscience Corp. Common Stock | LEXX | 1.5 | 2025-11-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.2 | $5,287,987.2 | Not reported | 1.22 |
| 215 | Lifecore Biomedical, Inc. Common Stock | LFCR | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.43 | $243,395,175.8 | Not reported | 15.12 |
| 216 | Lantern Pharma Inc. Common Stock | LTRN | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.83 | $10,610,841.18 | Not reported | Not reported |
| 217 | Lexeo Therapeutics, Inc. Common Stock | LXEO | 1.5 | 2025-12-15 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.21 | $263,368,478.55 | Not reported | 1.12 |
| 218 | Lexicon Pharmaceuticals, Inc. | LXRX | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.76 | $783,122,443.84 | Not reported | 4.49 |
| 219 | Maze Therapeutics, Inc. Common Stock | MAZE | 1.5 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $25.88 | $1,437,612,467.84 | Not reported | 3.17 |
| 220 | Moleculin Biotech, Inc. | MBRX | 1.5 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.42 | $3,010,400 | Not reported | 0.26 |
| 221 | MBX Biosciences, Inc. Common Stock | MBX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $53.25 | $2,564,525,112 | Not reported | 6.26 |
| 222 | MeiraGTx Holdings plc Ordinary Shares | MGTX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.5 | $1,008,451,458 | 12.77 | 4.67 |
| 223 | MIRA Pharmaceuticals, Inc. Common Stock | MIRA | 1.5 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.7 | $29,541,527.16 | Not reported | 3.62 |
| 224 | Medicinova, Inc. | MNOV | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.54 | $75,800,718.84 | Not reported | 2.03 |
| 225 | Monopar Therapeutics Inc. Common Stock | MNPR | 1.5 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $83.98 | $563,688,204.56 | Not reported | 4.31 |
| 226 | Marker Therapeutics, Inc. Common Stock | MRKR | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.95 | $15,839,470.65 | Not reported | 1.3 |
| 227 | Nektar Therapeutics | NKTR | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $40.8 | $1,393,034,155.2 | Not reported | 1.54 |
| 228 | Intellia Therapeutics, Inc | NTLA | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $12.6 | $1,765,596,331.8 | Not reported | 2.43 |
| 229 | Nutriband Inc. Common Stock | NTRB | 1.5 | 2025-12-01 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $6.05 | $73,541,882.15 | Not reported | 13.8 |
| 230 | Nuvation Bio Inc. | NUVB | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.95 | $1,738,060,003.35 | Not reported | 6.85 |
| 231 | Novavax Inc | NVAX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $11.01 | $1,816,052,443.26 | Not reported | Not reported |
| 232 | Ocular Therapeutix, Inc. | OCUL | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.51 | $1,649,315,168.68 | Not reported | 3.17 |
| 233 | Opko Health Inc. | OPK | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.37 | $1,022,469,668.25 | Not reported | 0.86 |
| 234 | Oric Pharmaceuticals, Inc. Common Stock | ORIC | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $12.03 | $1,246,941,451.68 | Not reported | 3.27 |
| 235 | Oruka Therapeutics, Inc. Common Stock | ORKA | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $77.28 | $5,116,685,538.72 | Not reported | 4.59 |
| 236 | Oramed Pharmaceuticals Inc. | ORMP | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.2 | $174,708,886.8 | 1 | 0.55 |
| 237 | PepGen Inc. Common Stock | PEPG | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.38 | $164,837,650.46 | Not reported | 1.38 |
| 238 | Praxis Precision Medicines, Inc. Common Stock | PRAX | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $263.55 | $7,358,312,837.4 | Not reported | 5.49 |
| 239 | PERRIGO COMPANY PLC | PRGO | 1.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $14.5 | $2,012,154,052.5 | Not reported | 0.8 |
| 240 | Prelude Therapeutics Incorporated | PRLD | 1.5 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.88 | $309,637,521.8 | Not reported | 2.32 |
| 241 | ProQR Therapeutics N.V. Ordinary Shares | PRQR | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.57 | $221,556,880.24 | Not reported | 3.82 |
| 242 | PTC Therapeutics, Inc. | PTCT | 1.5 | 2025-10-23 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $62.56 | $5,221,307,773.12 | Not reported | Not reported |
| 243 | Pelthos Therapeutics Inc. | PTHS | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $20.5 | $78,483,614.5 | Not reported | Not reported |
| 244 | Pulmatrix, Inc. Common Stock | PULM | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.53 | $5,577,404.42 | Not reported | 2.18 |
| 245 | Pyxis Oncology, Inc. Common Stock | PYXS | 1.5 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.99 | $165,982,019.5 | Not reported | 14.51 |
| 246 | Rani Therapeutics Holdings, Inc. Class A Common Stock | RANI | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.79 | $110,401,092.65 | Not reported | 2.3 |
| 247 | Ultragenyx Pharmaceutical Inc. | RARE | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.29 | $1,507,423,868.17 | Not reported | Not reported |
| 248 | REGENXBIO Inc. | RGNX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $8.09 | $534,046,723.28 | Not reported | 7.44 |
| 249 | Rallybio Corporation Common Stock | RLYB | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $16.99 | $90,225,378.01 | 1.98 | 0.95 |
| 250 | Roivant Sciences Ltd. Common Shares | ROIV | 1.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $34.21 | $24,710,670,343.15 | Not reported | 5.02 |
| 251 | Revolution Medicines, Inc. Common Stock | RVMD | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $188.12 | $40,320,966,954.16 | Not reported | 15.47 |
| 252 | Recursion Pharmaceuticals, Inc. Class A Common Stock | RXRX | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.95 | $2,114,601,571.5 | Not reported | 2.31 |
| 253 | SCYNEXIS, Inc. | SCYX | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.22 | $41,987,349.98 | Not reported | 0.63 |
| 254 | Septerna, Inc. Common Stock | SEPN | 1.5 | 2025-11-19 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $36.9 | $1,722,379,344.3 | Not reported | 4.45 |
| 255 | Sagimet Biosciences Inc. Series A Common Stock | SGMT | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $8.92 | $554,455,184.76 | Not reported | 2.16 |
| 256 | SELLAS Life Sciences Group, Inc. Common Stock | SLS | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $11.26 | $2,273,908,683.34 | Not reported | 16.52 |
| 257 | Syndax Pharmaceuticals, Inc. | SNDX | 1.5 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $16.9 | $1,509,120,753.4 | Not reported | 99.95 |
| 258 | Spero Therapeutics, Inc. Common Stock | SPRO | 1.5 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.14 | $66,387,702.78 | 8.99 | 1.5 |
| 259 | ARS Pharmaceuticals, Inc. Common Stock | SPRY | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.56 | $453,479,884.08 | Not reported | 36.24 |
| 260 | Protara Therapeutics, Inc. Common Stock | TARA | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.65 | $156,603,043.2 | Not reported | 0.97 |
| 261 | TON Strategy Company Common Stock | TONX | 1.5 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.24 | $178,433,244.36 | Not reported | 0.45 |
| 262 | Tempest Therapeutics, Inc. Common Stock | TPST | 1.5 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.77 | $12,304,146.47 | Not reported | Not reported |
| 263 | Entrada Therapeutics, Inc. Common Stock | TRDA | 1.5 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $5.53 | $215,319,779.57 | Not reported | 0.92 |
| 264 | Trevi Therapeutics, Inc. Common Stock | TRVI | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $12.83 | $1,827,252,660.82 | Not reported | 5.68 |
| 265 | Tvardi Therapeutics, Inc. Common Stock | TVRD | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.08 | $14,406,058.44 | Not reported | 1.72 |
| 266 | TherapeuticsMD, Inc. | TXMD | 1.5 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.01 | $23,264,467.62 | Not reported | 0.86 |
| 267 | Vir Biotechnology, Inc. Common Stock | VIR | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11.12 | $1,881,681,452.96 | Not reported | 1.92 |
| 268 | Vanda Pharmaceuticals Inc. | VNDA | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.53 | $273,895,972.11 | Not reported | 1.24 |
| 269 | Verrica Pharmaceuticals Inc. Common Stock | VRCA | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.18 | $71,807,325.48 | Not reported | 16.67 |
| 270 | Viridian Therapeutics, Inc. Common Stock | VRDN | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $18.34 | $2,077,780,213.46 | Not reported | 3.14 |
| 271 | Verastem, Inc. | VSTM | 1.5 | 2025-08-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $8.11 | $734,469,506.51 | Not reported | 14.69 |
| 272 | Vistagen Therapeutics, Inc. Common Stock | VTGN | 1.5 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.25 | $10,925,595.49 | Not reported | 0.45 |
| 273 | Whitehawk Therapeutics, Inc. Common Stock | WHWK | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.47 | $197,821,264.7 | Not reported | 1.08 |
| 274 | Xenetic Biosciences, Inc. | XBIO | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.12 | $4,967,543.72 | Not reported | 0.82 |
| 275 | Xenon Pharmaceuticals Inc | XENE | 1.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $36.16 | $3,501,750,021.12 | Not reported | 2.82 |
| 276 | Zenas BioPharma, Inc. Common Stock | ZBIO | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $26.24 | $1,710,237,211.52 | Not reported | 6.92 |
| 277 | Zevra Therapeutics, Inc. Common Stock | ZVRA | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11 | $653,221,591 | 11.21 | 3 |
| 278 | Aardvark Therapeutics, Inc. Common Stock | AARD | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.71 | $103,077,624.66 | Not reported | 1.38 |
| 279 | Achieve Life Sciences, Inc. | ACHV | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $7.19 | $739,868,903.1 | Not reported | Not reported |
| 280 | Acurx Pharmaceuticals, Inc. Common Stock | ACXP | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.25 | $6,587,401.25 | Not reported | 0.81 |
| 281 | AEON Biopharma, Inc. | AEON | 1 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.31 | $15,463,664.9 | Not reported | Not reported |
| 282 | Agenus Inc. | AGEN | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $7.54 | $339,453,868.78 | 3.69 | Not reported |
| 283 | Ainos, Inc. Common Stock | AIMD | 1 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.21 | $8,934,728.33 | Not reported | 2.72 |
| 284 | Alzamend Neuro, Inc. Common Stock | ALZN | 1 | 2025-09-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.34 | $6,466,468.82 | Not reported | 1.11 |
| 285 | Alto Neuroscience Inc. | ANRO | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $24.03 | $942,987,759.12 | Not reported | 4.3 |
| 286 | Annovis Bio, Inc. | ANVS | 1 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.17 | $49,849,197.84 | Not reported | Not reported |
| 287 | Apimeds Pharmaceuticals US, Inc. | APUS | 1 | 2025-08-19 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $5.51 | $8,315,240.18 | Not reported | 0.08 |
| 288 | Artelo Biosciences, Inc. Common Stock | ARTL | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-09 | $3.26 | $1,664,435.38 | Not reported | Not reported |
| 289 | Artiva Biotherapeutics, Inc. Common Stock | ARTV | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.8 | $332,452,822.8 | Not reported | 0.96 |
| 290 | Aspire-Lakewood Holdings, Inc. Common Stock | ASBP | 1 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $8.3 | $11,641,223.1 | Not reported | 0.99 |
| 291 | Atossa Therapeutics, Inc. Common Stock | ATOS | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.42 | $24,149,901.16 | Not reported | 0.9 |
| 292 | Azitra Inc | AZTR | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.13 | $7,999,693.94 | Not reported | 1.09 |
| 293 | Bausch Health Companies Inc | BHC | 1 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $6.04 | $2,258,902,988.44 | Not reported | Not reported |
| 294 | Belite Bio, Inc American Depositary Shares | BLTE | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $152.52 | $6,000,130,699.2 | Not reported | 7.79 |
| 295 | Benitec Biopharma Inc. Common Stock | BNTC | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $8.75 | $305,223,852.5 | Not reported | 1.72 |
| 296 | Cardinal Health, Inc. | CAH | 1 | 2025-10-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $238.96 | $55,576,295,962.88 | 32.42 | Not reported |
| 297 | CAMP4 Therapeutics Corporation Common Stock | CAMP | 1 | 2025-11-20 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.7 | $232,186,840 | Not reported | Not reported |
| 298 | Perspective Therapeutics, Inc. | CATX | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.71 | $309,351,006.73 | Not reported | 0.96 |
| 299 | Celularity Inc. Class A Common Stock | CELU | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.46 | $42,261,103.06 | Not reported | Not reported |
| 300 | Cingulate Inc. Common Stock | CING | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.88 | $70,964,110.88 | Not reported | 3.02 |
| 301 | Clene Inc. Common Stock | CLNN | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.88 | $49,852,230.44 | Not reported | Not reported |
| 302 | Context Therapeutics Inc. Common Stock | CNTX | 1 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.3 | $27,471,873.92 | Not reported | 0.72 |
| 303 | Cocrystal Pharma, Inc. Common Stock | COCP | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.07 | $20,611,624 | Not reported | 19.74 |
| 304 | Caribou Biosciences, Inc. Common Stock | CRBU | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.48 | $51,588,255.26 | Not reported | 0.53 |
| 305 | Cardiol Therapeutics Inc. Class A Common Shares | CRDL | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.3 | $157,966,828.5 | Not reported | 12.13 |
| 306 | CervoMed Inc. Common Stock | CRVO | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.28 | $49,590,634.88 | Not reported | 2.16 |
| 307 | Cel-Sci Corporation | CVM | 1 | 2025-12-23 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.95 | $34,298,524.65 | Not reported | 3.13 |
| 308 | Dare Bioscience, Inc. Common Stock | DARE | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.77 | $11,806,553.44 | Not reported | Not reported |
| 309 | DiaMedica Therapeutics Inc. Common Stock | DMAC | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $8.01 | $431,944,832.97 | Not reported | 11.27 |
| 310 | Dermata Therapeutics, Inc. Common Stock | DRMA | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.07 | $4,303,693.01 | Not reported | 1.23 |
| 311 | Dyadic International, Inc. | DYAI | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.44 | $16,193,359.61 | Not reported | Not reported |
| 312 | Edesa Biotech, Inc. Common Shares | EDSA | 1 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.66 | $35,286,173.46 | Not reported | Not reported |
| 313 | PMGC Holdings Inc. Common Stock | ELAB | 1 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.13 | $2,529,934.38 | Not reported | 0.15 |
| 314 | Enlivex Ltd. Ordinary Shares | ENLV | 1 | 2025-12-01 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.28 | $5,514,679.71 | 0 | 0 |
| 315 | Equillium, Inc. Common Stock | EQ | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.44 | $91,307,638.08 | Not reported | 1.63 |
| 316 | Estrella Immunopharma, Inc. Common Stock | ESLA | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.42 | $18,160,358.22 | Not reported | Not reported |
| 317 | Evotec SE American Depositary Shares | EVO | 1 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.57 | $558,225,767.98 | Not reported | Not reported |
| 318 | Fate Therapeutics, Inc. | FATE | 1 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.13 | $255,217,694.82 | Not reported | Not reported |
| 319 | Galectin Therapeutics Inc. | GALT | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.64 | $367,092,704.16 | Not reported | Not reported |
| 320 | Gain Therapeutics, Inc. Common Stock | GANX | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.62 | $70,484,444.69 | Not reported | 6.24 |
| 321 | GH Research PLC Ordinary Shares | GHRS | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $20.45 | $1,403,734,769.15 | Not reported | 5.02 |
| 322 | Genprex, Inc. Common Stock | GNPX | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.75 | $2,254,199.75 | Not reported | 0.15 |
| 323 | Gossamer Bio, Inc. Common Stock | GOSS | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $9.88 | $60,372,569.92 | Not reported | Not reported |
| 324 | GRI Bio, Inc. Common Stock | GRI | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.68 | $3,672,673.2 | Not reported | 0.36 |
| 325 | Fractyl Health, Inc. Common Stock | GUTS | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.23 | $56,110,895.01 | Not reported | Not reported |
| 326 | HCW Biologics Inc. Common Stock | HCWB | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.53 | $2,809,575.72 | Not reported | 0.38 |
| 327 | Heron Therapeutics, Inc. | HRTX | 1 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.36 | $68,005,096.37 | Not reported | 9.84 |
| 328 | TuHURA Biosciences, Inc. Common Stock | HURA | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.93 | $122,992,370.81 | Not reported | 6.65 |
| 329 | Impact BioMedical, Inc. | IBO | 1 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.11 | $35,114,520.69 | 44.51 | 2.51 |
| 330 | Icahn Enterprises L.P | IEP | 1 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.64 | $4,720,476,217.52 | Not reported | 2.2 |
| 331 | IGC Pharma, Inc. | IGC | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.28 | $29,454,103.88 | Not reported | 4.8 |
| 332 | Inhibikase Therapeutics, Inc. Common Stock | IKT | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.91 | $266,513,569 | Not reported | 1.74 |
| 333 | Imunon, Inc. Common Stock | IMNN | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.07 | $6,004,201.21 | Not reported | 1.43 |
| 334 | Immuneering Corporation Class A Common Stock | IMRX | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.74 | $241,968,283.48 | Not reported | 1.27 |
| 335 | MiNK Therapeutics, Inc. Common Stock | INKT | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11 | $56,133,022 | Not reported | Not reported |
| 336 | InMed Pharmaceuticals Inc. Common Shares | INM | 1 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.33 | $7,306,667.55 | Not reported | 6.8 |
| 337 | INmune Bio Inc. Common stock | INMB | 1 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.83 | $50,789,433.87 | Not reported | 2.49 |
| 338 | Inovio Pharmaceuticals, Inc. | INO | 1 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.09 | $112,703,294.62 | Not reported | 25.78 |
| 339 | Opus Genetics, Inc. Common Stock | IRD | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.46 | $371,053,370.58 | Not reported | Not reported |
| 340 | INVO Fertility, Inc. Common Stock | IVF | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.74 | $1,855,407.76 | Not reported | 0.11 |
| 341 | Jupiter Neurosciences, Inc. Common Stock | JUNS | 1 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.77 | $2,133,124.37 | Not reported | Not reported |
| 342 | Kairos Pharma, Ltd. | KAPA | 1 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.96 | $3,248,274.99 | Not reported | Not reported |
| 343 | Kodiak Sciences Inc Common Stock | KOD | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $94.26 | $5,924,189,816.82 | Not reported | 96.97 |
| 344 | Kiora Pharmaceuticals, Inc. Common Stock | KPRX | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.53 | $11,193,699.11 | Not reported | 0.66 |
| 345 | Korro Bio, Inc. Common Stock | KRRO | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $10.58 | $155,797,334.68 | Not reported | 1.51 |
| 346 | Pasithea Therapeutics Corp. Common Stock | KTTA | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.44 | $14,732,430.12 | Not reported | 0.3 |
| 347 | LB Pharmaceuticals Inc Common Stock | LBRX | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $34.61 | $1,116,490,046.75 | Not reported | 3.36 |
| 348 | Liminatus Pharma, Inc. Class A Common Stock | LIMN | 1 | 2025-10-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.69 | $4,956,433.83 | Not reported | 16.49 |
| 349 | Lite Strategy, Inc. Common Stock | LITS | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.22 | $37,096,866.96 | Not reported | 0.89 |
| 350 | Lipocine Inc. | LPCN | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.93 | $15,911,408.29 | Not reported | 0.73 |
| 351 | Lisata Therapeutics, Inc. Common Stock | LSTA | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.2 | $10,813,124.4 | Not reported | 1.35 |
| 352 | MAIA Biotechnology, Inc. | MAIA | 1 | 2025-11-27 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.15 | $69,949,720.6 | Not reported | 3.38 |
| 353 | Medicus Pharma Ltd. Common Stock | MDCX | 1 | 2025-11-21 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.1 | $6,438,104.16 | Not reported | Not reported |
| 354 | Matinas BioPharma Holdings, Inc. | MTNB | 1 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.83 | $1,208,633.57 | Not reported | 0.67 |
| 355 | MetaVia Inc. Common Stock | MTVA | 1 | 2025-08-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.34 | $8,828,055.34 | Not reported | 1.29 |
| 356 | Minerva Neurosciences, Inc | NERV | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.22 | $153,747,139.98 | Not reported | Not reported |
| 357 | Neuphoria Therapeutics Inc. Common Stock | NEUP | 1 | 2025-09-29 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.35 | $100,710.94 | Not reported | 0 |
| 358 | NanoViricides Inc. | NNVC | 1 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.31 | $33,437,750 | Not reported | 3.86 |
| 359 | NRX Pharmaceuticals, Inc. Common Stock | NRXP | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.89 | $125,124,766.63 | Not reported | Not reported |
| 360 | Nasus Pharma Ltd. | NSRX | 1 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.63 | $42,521,123.04 | Not reported | 15.36 |
| 361 | NeOnc Technologies Holdings, Inc. Common Stock | NTHI | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.53 | $65,619,003.45 | Not reported | Not reported |
| 362 | NextCure, Inc. Common Stock | NXTC | 1 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $6.78 | $31,034,494.02 | Not reported | 2.55 |
| 363 | OnKure Therapeutics, Inc. Class A Common Stock | OKUR | 1 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.3 | $93,141,510.7 | Not reported | 0.54 |
| 364 | OKYO Pharma Limited Ordinary Shares | OKYO | 1 | 2025-09-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.39 | $72,946,542.53 | Not reported | Not reported |
| 365 | Omeros Corporation | OMER | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $19.12 | $1,384,064,601.92 | 11.09 | Not reported |
| 366 | OS Therapies Incorporated | OSTX | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.62 | $74,723,836.5 | Not reported | Not reported |
| 367 | Outlook Therapeutics, Inc. Common Stock | OTLK | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.56 | $137,304,420.46 | Not reported | Not reported |
| 368 | Ovid Therapeutics Inc. Common Stock | OVID | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.34 | $456,996,985.38 | Not reported | 2.18 |
| 369 | Processa Pharmaceuticals, Inc. Common | PCSA | 1 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.35 | $3,771,071.1 | Not reported | Not reported |
| 370 | PDS Biotechnology Corporation Common Stock | PDSB | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.02 | $57,090,764.76 | Not reported | Not reported |
| 371 | Precigen, Inc. Common Stock | PGEN | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.6 | $2,721,067,877.2 | Not reported | 62.44 |
| 372 | PMV Pharmaceuticals, Inc | PMVP | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.49 | $79,652,506.42 | Not reported | 1.11 |
| 373 | Palatin Technologies, Inc. Common Stock | PTN | 1 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $9.01 | $16,046,260.39 | Not reported | 2.4 |
| 374 | Palvella Therapeutics, Inc. Common Stock | PVLA | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $131.34 | $1,892,400,175.38 | Not reported | 8.73 |
| 375 | PolyPid Ltd. Ordinary Shares | PYPD | 1 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.9 | $99,527,653.4 | Not reported | 9.07 |
| 376 | Q/C Technologies, Inc. Common Stock | QCLS | 1 | 2025-06-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.64 | $5,214,469.85 | Not reported | 0.27 |
| 377 | Quince Therapeutics, Inc. Common Stock | QNCX | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $29.36 | $29,860,969.68 | Not reported | 0.28 |
| 378 | Q32 Bio Inc. Common Stock | QTTB | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $8.09 | $240,834,979.94 | 7.13 | 2.27 |
| 379 | Revelation Biosciences, Inc. Common Stock | REVB | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.77 | $3,082,765.64 | Not reported | 0.31 |
| 380 | Rafael Holdings, Inc. Class B Common Stock | RFL | 1 | 2025-12-15 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.48 | $76,959,994.08 | Not reported | 0.95 |
| 381 | Relmada Therapeutics, Inc. Common Stock | RLMD | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.17 | $338,143,411.82 | Not reported | 1.64 |
| 382 | Rein Therapeutics, Inc. Common Stock | RNTX | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.77 | $66,365,227.72 | Not reported | 1.2 |
| 383 | RenovoRx, Inc. Common Stock | RNXT | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.33 | $60,022,245.64 | Not reported | 6.68 |
| 384 | SAB Biotherapeutics, Inc. Common Stock | SABS | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.89 | $262,950,603.52 | Not reported | 1.22 |
| 385 | Scilex Holding Company Common Stock | SCLX | 1 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.96 | $25,139,280 | Not reported | Not reported |
| 386 | Scienture Holdings, Inc. Common Stock | SCNX | 1 | 2025-08-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.86 | $6,340,304.76 | Not reported | 0.1 |
| 387 | Shuttle Pharmaceuticals Holdings, Inc. Common Stock | SHPH | 1 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $5.55 | $5,556,465.75 | Not reported | 0.29 |
| 388 | Silo Pharma, Inc. Common Stock | SILO | 1 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.45 | $2,302,962.5 | Not reported | 0.47 |
| 389 | Sionna Therapeutics, Inc. Common Stock | SION | 1 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.9 | $221,540,755.1 | Not reported | 0.83 |
| 390 | Skye Bioscience, Inc. Common Stock | SKYE | 1 | 2025-08-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.68 | $7,438,497.36 | Not reported | Not reported |
| 391 | Solid Biosciences Inc. Common Stock | SLDB | 1 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.82 | $731,276,123.16 | Not reported | 1.95 |
| 392 | Summit Therapeutics Inc. Common Stock | SMMT | 1 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $17.17 | $13,697,360,666.34 | Not reported | 21.74 |
| 393 | SciSparc Ltd. Ordinary Shares | SPRC | 1 | 2025-09-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.43 | $2,573,710.39 | Not reported | Not reported |
| 394 | Surrozen, Inc. Common | SRZN | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $27.97 | $328,747,017.26 | Not reported | Not reported |
| 395 | Sutro Biopharma, Inc. | STRO | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.32 | $254,023,539.72 | Not reported | Not reported |
| 396 | 60 Degrees Pharmaceuticals, Inc. Common Stock | SXTP | 1 | 2025-11-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.97 | $3,420,270.83 | Not reported | 1.35 |
| 397 | Alaunos Therapeutics, Inc. Common Stock | TCRT | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.78 | $1,984,114.88 | Not reported | 3.04 |
| 398 | Telomir Pharmaceuticals, Inc. Common Stock | TELO | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.15 | $79,091,199.4 | Not reported | 15.71 |
| 399 | Talphera, Inc. Common Stock | TLPH | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.08 | $56,058,259.68 | Not reported | 3.89 |
| 400 | TriSalus Life Sciences, Inc. Common Stock | TLSI | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.13 | $254,303,098 | Not reported | 38.82 |
| 401 | Theriva Biologics, Inc. | TOVX | 1 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.23 | $10,422,224.9 | Not reported | 0.86 |
| 402 | Traws Pharma, Inc. Common Stock | TRAW | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.48 | $7,381,383.44 | Not reported | 4.37 |
| 403 | Turn Therapeutics Inc. Common Stock | TTRX | 1 | 2025-09-16 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11.39 | $339,285,775.6 | Not reported | 493.95 |
| 404 | Tevogen Inc. Common Stock | TVGN | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.06 | $45,971,472.4 | Not reported | Not reported |
| 405 | Vivani Medical, Inc. Common Stock (DE) | VANI | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.23 | $110,950,127.88 | Not reported | 5.85 |
| 406 | Veru Inc. | VERU | 1 | 2025-12-01 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.42 | $41,261,774.4 | Not reported | 1.45 |
| 407 | VivoSim Labs, Inc. Common Stock | VIVS | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.18 | $619,149.38 | Not reported | Not reported |
| 408 | Vor Biopharma Inc. Common Stock | VOR | 1 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $19.13 | $1,131,774,684.22 | 1.8 | Not reported |
| 409 | vTv Therapeutics Inc. Class A Common Stock | VTVT | 1 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $30.08 | $118,934,154.24 | Not reported | 1.51 |
| 410 | XBiotech Inc | XBIT | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.2 | $67,073,008.2 | Not reported | 0.52 |
| 411 | XORTX Therapeutics Inc. Common Stock | XRTX | 1 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.85 | $3,360,645.25 | Not reported | 1.61 |
No matching rows. Clear the filter to see all records.
411 companies with eligible ratings and dated fundamentals, from 542 eligible companies in this selection.
Dates and coverage
Report dates range from 2025-06-30 to 2025-12-31. Market observations range from 2026-10-08 to 2026-10-09. These dates may differ across companies. Daily closes are not synchronized live quotes.
The selection includes 127 companies without a report, 0 with invalid latest rating metadata, 2 with older reports, 2 with missing required fundamentals and 0 with out-of-date market observations. Missing companies receive no substitute score.
How the ranking is built
The ranking uses the latest stored report at or before the refresh cutoff for each active eligible company. The report date, fiscal year/period and producing model remain visible. The latest invalid score is excluded; an older favorable score does not replace it. Publication policy stock-ratings-v1 accepts report ages up to 550 days and market observations up to 10 calendar days, with a positive close and market capitalization. Optional missing ratios remain not reported.
Report ages can differ substantially, particularly between annual and quarterly reports. Different producing models may also use different judgments. Read the date, fiscal period and model before comparing scores. Private report analysis and account data are not published here.
A refresh reads existing reports and market data. It does not rerun a model or create a new analysis. Compare business fundamentals and your own research constraints alongside the score before making a decision.